Two Sigma Advisers’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $851K | Sell |
|
|||||
|
2025
Q1 | $752K | Buy |
|
|||||
|
2024
Q4 | $95.8K | Sell |
|
|||||
|
2024
Q3 | $324K | Sell |
|
|||||
|
2024
Q2 | $206K | Sell |
|
|||||
|
2024
Q1 | $329K | Sell |
|
|||||
|
2023
Q4 | $415K | Sell |
|
|||||
|
2023
Q3 | $363K | Buy |
|
|||||
|
2023
Q2 | $409K | Sell |
|
|||||
|
2023
Q1 | $170K | Sell |
|
|||||
|
2022
Q4 | $221K | Sell |
|
|||||
|
2022
Q3 | $393K | Buy |
|
|||||
|
2022
Q2 | $370K | Sell |
|
|||||
|
2022
Q1 | $684K | Sell |
|
|||||
|
2021
Q4 | $1.84M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $770K | Sell |
|
|||||
|
2021
Q1 | $899K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $100K | Buy |
|
|||||
|
2020
Q1 | $61K | Buy |
|
|||||
|
2019
Q4 | $90K | Buy |
|